Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients.

Powrózek T, Porgador A, Małecka-Massalska T.

Expert Rev Mol Diagn. 2020 Jan;20(1):31-39. doi: 10.1080/14737159.2020.1699062. Epub 2019 Dec 3.

PMID:
31778325
2.

Datasets of RT spoofing attacks on MIL-STD-1553 communication traffic.

Yahalom R, Barishev D, Steren A, Nameri Y, Roytman M, Porgador A, Elovici Y.

Data Brief. 2019 Mar 20;23:103863. doi: 10.1016/j.dib.2019.103863. eCollection 2019 Apr.

3.

Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.

Sobarzo A, Stonier SW, Radinsky O, Gelkop S, Kuehne AI, Edri A, Herbert AS, Fedida-Metula S, Lutwama JJ, Yavelsky V, Davis C, Porgador A, Dye JM, Lobel L.

EBioMedicine. 2019 Aug;46:215-226. doi: 10.1016/j.ebiom.2019.07.021. Epub 2019 Jul 17.

4.

Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.

Kundu K, Ghosh S, Sarkar R, Edri A, Brusilovsky M, Gershoni-Yahalom O, Yossef R, Shemesh A, Soria JC, Lazar V, Joshua BZ, Campbell KS, Elkabets M, Porgador A.

Cancer Immunol Res. 2019 Jul;7(7):1120-1134. doi: 10.1158/2326-6066.CIR-19-0023. Epub 2019 Jun 4.

PMID:
31164357
5.

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy.

Ghosh S, Prasad M, Kundu K, Cohen L, Yegodayev KM, Zorea J, Joshua BZ, Lasry B, Dimitstein O, Bahat-Dinur A, Mizrachi A, Lazar V, Elkabets M, Porgador A.

Front Oncol. 2019 Jan 22;9:17. doi: 10.3389/fonc.2019.00017. eCollection 2019.

6.

Selective Labeling and Growth Inhibition of Pseudomonas aeruginosa by Aminoguanidine Carbon Dots.

Otis G, Bhattacharya S, Malka O, Kolusheva S, Bolel P, Porgador A, Jelinek R.

ACS Infect Dis. 2019 Feb 8;5(2):292-302. doi: 10.1021/acsinfecdis.8b00270. Epub 2019 Jan 11.

PMID:
30589261
7.

Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.

Berhani O, Glasner A, Kahlon S, Duev-Cohen A, Yamin R, Horwitz E, Enk J, Moshel O, Varvak A, Porgador A, Jonjic S, Mandelboim O.

Eur J Immunol. 2019 Feb;49(2):228-241. doi: 10.1002/eji.201847611. Epub 2018 Dec 17.

8.

Nanoscale Mechanosensing of Natural Killer Cells is Revealed by Antigen-Functionalized Nanowires.

Le Saux G, Bar-Hanin N, Edri A, Hadad U, Porgador A, Schvartzman M.

Adv Mater. 2019 Jan;31(4):e1805954. doi: 10.1002/adma.201805954. Epub 2018 Nov 28.

PMID:
30488552
9.

Natural killer cells' immune response requires a minimal nanoscale distribution of activating antigens.

Keydar Y, Le Saux G, Pandey A, Avishay E, Bar-Hanin N, Esti T, Bhingardive V, Hadad U, Porgador A, Schvartzman M.

Nanoscale. 2018 Aug 2;10(30):14651-14659. doi: 10.1039/c8nr04038a.

PMID:
30033475
10.

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells.

Edri A, Shemesh A, Iraqi M, Matalon O, Brusilovsky M, Hadad U, Radinsky O, Gershoni-Yahalom O, Dye JM, Mandelboim O, Barda-Saad M, Lobel L, Porgador A.

Front Immunol. 2018 Jul 2;9:1428. doi: 10.3389/fimmu.2018.01428. eCollection 2018.

11.

NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.

Shemesh A, Kundu K, Peleg R, Yossef R, Kaplanov I, Ghosh S, Khrapunsky Y, Gershoni-Yahalom O, Rabinski T, Cerwenka A, Atlas R, Porgador A.

Front Immunol. 2018 May 23;9:1114. doi: 10.3389/fimmu.2018.01114. eCollection 2018.

12.

Spatial and Chemical Surface Guidance of NK Cell Cytotoxic Activity.

Le Saux G, Edri A, Keydar Y, Hadad U, Porgador A, Schvartzman M.

ACS Appl Mater Interfaces. 2018 Apr 11;10(14):11486-11494. doi: 10.1021/acsami.7b19643. Epub 2018 Mar 30.

PMID:
29557634
13.

Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints.

Shemesh A, Brusilovsky M, Kundu K, Ottolenghi A, Campbell KS, Porgador A.

Cancer Immunol Immunother. 2018 Dec;67(12):1871-1883. doi: 10.1007/s00262-017-2104-x. Epub 2017 Dec 20. Review.

PMID:
29264698
14.

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor.

Eisenberg V, Shamalov K, Meir S, Hoogi S, Sarkar R, Pinker S, Markel G, Porgador A, Cohen CJ.

Front Immunol. 2017 Sep 29;8:1212. doi: 10.3389/fimmu.2017.01212. eCollection 2017.

15.

Nitric Oxide Sensing through Azo-Dye Formation on Carbon Dots.

Bhattacharya S, Sarkar R, Chakraborty B, Porgador A, Jelinek R.

ACS Sens. 2017 Aug 25;2(8):1215-1224. doi: 10.1021/acssensors.7b00356. Epub 2017 Aug 16.

PMID:
28770991
16.

Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI.

Radinsky O, Edri A, Brusilovsky M, Fedida-Metula S, Sobarzo A, Gershoni-Yahalom O, Lutwama J, Dye J, Lobel L, Porgador A.

Sci Rep. 2017 Jul 20;7(1):6054. doi: 10.1038/s41598-017-06226-8.

17.

Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression.

Pazina T, Shemesh A, Brusilovsky M, Porgador A, Campbell KS.

Front Immunol. 2017 Mar 30;8:369. doi: 10.3389/fimmu.2017.00369. eCollection 2017. Review.

18.

Adipose tissue supports normalization of macrophage and liver lipid handling in obesity reversal.

Vatarescu M, Bechor S, Haim Y, Pecht T, Tarnovscki T, Slutsky N, Nov O, Shapiro H, Shemesh A, Porgador A, Bashan N, Rudich A.

J Endocrinol. 2017 Jun;233(3):293-305. doi: 10.1530/JOE-17-0007. Epub 2017 Mar 30.

19.

Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity.

Shemer-Avni Y, Kundu K, Shemesh A, Brusilovsky M, Yossef R, Meshesha M, Solomon-Alemayehu S, Levin S, Gershoni-Yahalom O, Campbell KS, Porgador A.

Front Immunol. 2017 Feb 15;8:161. doi: 10.3389/fimmu.2017.00161. eCollection 2017.

20.

Detection of Reactive Oxygen Species by a Carbon-Dot-Ascorbic Acid Hydrogel.

Bhattacharya S, Sarkar R, Nandi S, Porgador A, Jelinek R.

Anal Chem. 2017 Jan 3;89(1):830-836. doi: 10.1021/acs.analchem.6b03749. Epub 2016 Dec 19.

PMID:
27991760
21.

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint.

Shemesh A, Kugel A, Steiner N, Yezersky M, Tirosh D, Edri A, Teltsh O, Rosental B, Sheiner E, Rubin E, Campbell KS, Porgador A.

Oncotarget. 2016 Oct 25;7(43):70912-70923. doi: 10.18632/oncotarget.12292.

22.

Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation.

Elhaik Goldman S, Moshkovits I, Shemesh A, Filiba A, Tsirulsky Y, Vronov E, Shagan M, Apte RN, Benharroch DA, Karo-Atar D, Dagan R, Munitz A, Mizrachi Nebenzahl Y, Porgador A.

PLoS One. 2016 Aug 31;11(8):e0160779. doi: 10.1371/journal.pone.0160779. eCollection 2016.

23.

Survival in acute myeloid leukemia is associated with NKp44 splice variants.

Shemesh A, Brusilovsky M, Hadad U, Teltsh O, Edri A, Rubin E, Campbell KS, Rosental B, Porgador A.

Oncotarget. 2016 May 31;7(22):32933-45. doi: 10.18632/oncotarget.8782.

24.

Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.

Elhaik Goldman S, Dotan S, Talias A, Lilo A, Azriel S, Malka I, Portnoi M, Ohayon A, Kafka D, Ellis R, Elkabets M, Porgador A, Levin D, Azhari R, Swiatlo E, Ling E, Feldman G, Tal M, Dagan R, Mizrachi Nebenzahl Y.

Int J Mol Med. 2016 Apr;37(4):1127-38. doi: 10.3892/ijmm.2016.2512. Epub 2016 Mar 1.

PMID:
26935978
25.

NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization.

Hadad U, Thauland TJ, Martinez OM, Butte MJ, Porgador A, Krams SM.

Front Immunol. 2015 Sep 25;6:495. doi: 10.3389/fimmu.2015.00495. eCollection 2015.

26.

Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome.

Teltsh O, Porgador A, Rubin E.

Oncotarget. 2015 Oct 20;6(32):33191-205. doi: 10.18632/oncotarget.5052.

27.

First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue.

Shemesh A, Tirosh D, Sheiner E, Tirosh NB, Brusilovsky M, Segev R, Rosental B, Porgador A.

Front Immunol. 2015 Jun 1;6:189. doi: 10.3389/fimmu.2015.00189. eCollection 2015.

28.

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer.

Lazar V, Rubin E, Depil S, Pawitan Y, Martini JF, Gomez-Navarro J, Yver A, Kan Z, Dry JR, Kehren J, Validire P, Rodon J, Vielh P, Ducreux M, Galbraith S, Lehnert M, Onn A, Berger R, Pierotti MA, Porgador A, Pramesh CS, Ye DW, Carvalho AL, Batist G, Le Chevalier T, Morice P, Besse B, Vassal G, Mortlock A, Hansson J, Berindan-Neagoe I, Dann R, Haspel J, Irimie A, Laderman S, Nechushtan H, Al Omari AS, Haywood T, Bresson C, Soo KC, Osman I, Mata H, Lee JJ, Jhaveri K, Meurice G, Palmer G, Lacroix L, Koscielny S, Eterovic KA, Blay JY, Buller R, Eggermont A, Schilsky RL, Mendelsohn J, Soria JC, Rothenberg M, Scoazec JY, Hong WK, Kurzrock R.

Oncotarget. 2015 Jun 10;6(16):14139-52.

29.

Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Arnon TI, Markel G, Bar-Ilan A, Hanna J, Fima E, Benchetrit F, Galili R, Cerwenka A, Benharroch D, Sion-Vardy N, Porgador A, Mandelboim O.

PLoS One. 2015 May 4;10(5):e0128052. doi: 10.1371/journal.pone.0128052. eCollection 2015. No abstract available.

30.

Central nervous system acute lymphoblastic leukemia: role of natural killer cells.

Frishman-Levy L, Shemesh A, Bar-Sinai A, Ma C, Ni Z, Frenkel S, Muench V, Bruckmueller H, Vokuhl C, Debatin KM, Eckert C, Stanulla M, Schrappe M, Campbell KS, Loewenthal R, Schewe DM, Hochman J, Meyer LH, Kaufman D, Cario G, Porgador A, Izraeli S.

Blood. 2015 May 28;125(22):3420-31. doi: 10.1182/blood-2014-08-595108. Epub 2015 Apr 20. Erratum in: Blood. 2015 Jul 16;126(3):425.

PMID:
25896649
31.

Retraction. Novel APC-like properties of human NK cells directly regulate T cell activation.

Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O.

J Clin Invest. 2015 Apr;125(4):1763. doi: 10.1172/JCI81527. Epub 2015 Apr 1. No abstract available.

32.

Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals.

Edri-Brami M, Sharoni H, Hayoun D, Skutelsky L, Nemirovsky A, Porgador A, Lichtenstein RG.

Exp Neurol. 2015 May;267:95-106. doi: 10.1016/j.expneurol.2015.02.023. Epub 2015 Feb 26.

PMID:
25725350
33.

Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.

Yossef R, Gur C, Shemesh A, Guttman O, Hadad U, Nedvetzki S, Miletić A, Nalbandyan K, Cerwenka A, Jonjic S, Mandelboim O, Porgador A.

PLoS One. 2015 Feb 26;10(2):e0118936. doi: 10.1371/journal.pone.0118936. eCollection 2015.

34.

Colorimetric polymer assay for the diagnosis of plasma lipids atherogenic quality in hypercholesterolemic patients.

Mann E, Kolusheva S, Yossef R, Porgador A, Aviram M, Jelinek R.

Mol Diagn Ther. 2015 Feb;19(1):35-43. doi: 10.1007/s40291-014-0127-y.

PMID:
25680504
35.

Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.

Brusilovsky M, Radinsky O, Cohen L, Yossef R, Shemesh A, Braiman A, Mandelboim O, Campbell KS, Porgador A.

Eur J Immunol. 2015 Apr;45(4):1180-91. doi: 10.1002/eji.201445177. Epub 2015 Jan 21.

36.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508. Review.

37.

An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.

Tal Y, Yaakobi S, Horovitz-Fried M, Safyon E, Rosental B, Porgador A, Cohen CJ.

Oncotarget. 2014 Nov 15;5(21):10949-58.

38.

α1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet β-cells in favor of protection from autoimmune diabetes.

Guttman O, Yossef R, Freixo-Lima G, Rider P, Porgador A, Lewis EC.

Immunology. 2014 Oct 13. doi: 10.1111/imm.12403. [Epub ahead of print]

39.

Carbohydrate-mediated modulation of NK cell receptor function: structural and functional influences of heparan sulfate moieties expressed on NK cell surface.

Brusilovsky M, Radinsky O, Yossef R, Campbell KS, Porgador A.

Front Oncol. 2014 Jul 16;4:185. doi: 10.3389/fonc.2014.00185. eCollection 2014. Review. No abstract available.

40.

Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.

Brusilovsky M, Cordoba M, Rosental B, Hershkovitz O, Andrake MD, Pecherskaya A, Einarson MB, Zhou Y, Braiman A, Campbell KS, Porgador A.

J Immunol. 2013 Nov 15;191(10):5256-67. doi: 10.4049/jimmunol.1302079. Epub 2013 Oct 14.

41.

RORγt⁺ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44.

Glatzer T, Killig M, Meisig J, Ommert I, Luetke-Eversloh M, Babic M, Paclik D, Blüthgen N, Seidl R, Seifarth C, Gröne J, Lenarz M, Stölzel K, Fugmann D, Porgador A, Hauser A, Karlas A, Romagnani C.

Immunity. 2013 Jun 27;38(6):1223-35. doi: 10.1016/j.immuni.2013.05.013. Epub 2013 Jun 20.

42.

NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice.

Muchnik L, Adawi A, Ohayon A, Dotan S, Malka I, Azriel S, Shagan M, Portnoi M, Kafka D, Nahmani H, Porgador A, Gershoni JM, Morrison DA, Mitchell A, Tal M, Ellis R, Dagan R, Nebenzahl YM.

PLoS One. 2013;8(4):e61128. doi: 10.1371/journal.pone.0061128. Epub 2013 Apr 8. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/7fbc524a-4035-401e-8cc7-93393afc35fd. Gershoni, Johnatan M [corrected to Gershoni, Jonathan M].

43.

Dual fluorescent labelling of the human malaria parasite Plasmodium falciparum for the analysis of the ABC type transporter pfmdr2.

Rosental B, Hadad U, Sinay R, Braiman A, Porgador A, Pollack Y.

Malar J. 2012 Nov 8;11:371. doi: 10.1186/1475-2875-11-371.

44.

A novel "reactomics" approach for cancer diagnostics.

Kolusheva S, Yossef R, Kugel A, Hanin-Avraham N, Cohen M, Rubin E, Porgador A.

Sensors (Basel). 2012;12(5):5572-85. doi: 10.3390/s120505572. Epub 2012 May 2.

45.

A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen.

Rosental B, Hadad U, Brusilovsky M, Campbell KS, Porgador A.

Oncoimmunology. 2012 Jul 1;1(4):572-574.

46.

Array-based disease diagnostics using lipid/polydiacetylene vesicles encapsulated in a sol-gel matrix.

Kolusheva S, Yossef R, Kugel A, Katz M, Volinsky R, Welt M, Hadad U, Drory V, Kliger M, Rubin E, Porgador A, Jelinek R.

Anal Chem. 2012 Jul 17;84(14):5925-31. doi: 10.1021/ac300449u. Epub 2012 Jul 6.

PMID:
22746165
47.

Glycans in sera of amyotrophic lateral sclerosis patients and their role in killing neuronal cells.

Edri-Brami M, Rosental B, Hayoun D, Welt M, Rosen H, Wirguin I, Nefussy B, Drory VE, Porgador A, Lichtenstein RG.

PLoS One. 2012;7(5):e35772. doi: 10.1371/journal.pone.0035772. Epub 2012 May 30.

48.

Dimerization of NKp46 receptor is essential for NKp46-mediated lysis: characterization of the dimerization site by epitope mapping.

Jaron-Mendelson M, Yossef R, Appel MY, Zilka A, Hadad U, Afergan F, Rosental B, Engel S, Nedvetzki S, Braiman A, Porgador A.

J Immunol. 2012 Jun 15;188(12):6165-74. doi: 10.4049/jimmunol.1102496. Epub 2012 May 21.

49.

Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands.

Brusilovsky M, Rosental B, Shemesh A, Appel MY, Porgador A.

J Immunotoxicol. 2012 Jul-Sep;9(3):267-74. doi: 10.3109/1547691X.2012.675366. Epub 2012 Apr 23. Review.

PMID:
22524686
50.

The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells.

Rosental B, Appel MY, Yossef R, Hadad U, Brusilovsky M, Porgador A.

Curr Med Chem. 2012;19(12):1780-91. Review.

PMID:
22414084

Supplemental Content

Loading ...
Support Center